We are pleased to announce that BioMed ENT has been granted U.S. Patent No. 12,370,287 B2 for our Epi-Stop™ Nasal Gel technology. This patent, titled “Particulate Gel for the Treatment of a Bleeding in the Sinus or Nasal Cavity,” recognizes our continued innovation in the field of hemostatic nasal treatments.

The Epi-Stop™ Nasal Gel represents an important advancement in the management of nasal bleeding, offering improved stability, absorption, and healing characteristics designed specifically for ENT applications.

The patent preview is now available on our Resource Center.